Abbott Laboratories (ABT)
Operating return on assets (Operating ROA)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | 6,943,000 | 6,896,000 | 6,806,000 | 6,746,000 | 6,974,000 | 6,414,000 | 6,415,000 | 7,128,000 | 8,362,000 | 9,436,000 | 10,212,000 | 9,228,000 | 8,425,000 | 8,479,000 | 7,428,000 | 6,708,000 | 5,357,000 | 4,314,000 | 4,017,000 | 4,551,000 |
| Total assets | US$ in thousands | 81,414,000 | 74,356,000 | 73,017,000 | 72,467,000 | 73,214,000 | 72,090,000 | 73,354,000 | 73,794,000 | 74,438,000 | 72,801,000 | 74,202,000 | 74,007,000 | 75,196,000 | 73,795,000 | 73,269,000 | 72,785,000 | 72,548,000 | 69,043,000 | 68,793,000 | 66,712,000 |
| Operating ROA | 8.53% | 9.27% | 9.32% | 9.31% | 9.53% | 8.90% | 8.75% | 9.66% | 11.23% | 12.96% | 13.76% | 12.47% | 11.20% | 11.49% | 10.14% | 9.22% | 7.38% | 6.25% | 5.84% | 6.82% |
December 31, 2024 calculation
Operating ROA = Operating income (ttm) ÷ Total assets
= $6,943,000K ÷ $81,414,000K
= 8.53%
Abbott Laboratories' operating return on assets (operating ROA) has shown fluctuations over the period from March 31, 2020, to December 31, 2024. The trend indicates an initial increase from 6.82% in March 2020 to a peak of 13.76% in June 2022. This upward trajectory demonstrates improved operational efficiency and profitability during this period.
However, there was a decline in operating ROA from the peak in June 2022 to 8.53% by December 31, 2024. This decrease suggests a potential decline in the company's ability to generate profits from its assets efficiently.
Overall, the average operating return on assets for the period under review appears to be relatively healthy, with fluctuations reflecting changes in operational performance and efficiency. Monitoring this metric closely can provide insights into Abbott Laboratories' ability to utilize its assets effectively to generate profits.
Peer comparison
Dec 31, 2024